¼¼°èÀÇ ÆéƼµå ÇÕ¼º ½ÃÀå º¸°í¼­(2025³â)
Peptide Synthesis Global Market Report 2025
»óǰÄÚµå : 1825500
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 250 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,457,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,334,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,211,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÆéƼµå ÇÕ¼º ½ÃÀåÀÇ ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. 2029³â¿¡´Â CAGR 9.6%·Î 89¾ï 2,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ¿¹Ãø±â°£ÀÇ ¼ºÀåÀº Ä¡·á¿ë ÆéƼµåÀÇ ±Þ¼ºÀå, ¸ÂÃãÇü ÆéƼµå¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ½Å¾à °³¹ß¿¡ À־ÀÇ ¿ªÇÒ Áõ°¡, ½ºÅ©¸®´×¿ë ÆéƼµå ¶óÀ̺귯¸®¿¡ ´ëÇÑ ÁÖ¸ñ µî¿¡ ±âÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÆéƼµå ¸ð¹æÇ°ÀÇ °³¹ß, ½Å±Ô ¾Æ¹Ì³ë»ê À¯µµÃ¼ÀÇ Ã¤¿ë, ÆéƼµåȯȭ ±â¼ú, °í»ó ÆéƼµå ÇÕ¼º(SPPs)ÀÇ Çõ½Å, Ŭ¸¯ Äɹ̽ºÆ®¸®ÀÇ È°¿ë µîÀÌ ÀÖ½À´Ï´Ù.

ÇâÈÄ 5³â°£ÀÇ ¿¹Ãø ¼ºÀå·ü 9.6%´Â °ú°Å ¿¹Ãø¿¡¼­ 0.1% ¼ÒÆø °¨¼ÒÇÑ ¼öÄ¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀå¼¼ µÐÈ­´Â ÁÖ·Î ¹Ì±¹°ú ´Ù¸¥ ±¹°¡ °£ÀÇ °ü¼¼ÀÇ ¿µÇâ ¶§¹®ÀÔ´Ï´Ù. °ü¼¼À庮Àº ½ºÀ§½º³ª Áß±¹¿¡¼­ Á¶´ÞÇÏ´Â ÀÚµ¿ ÆéƼµå ÇÕ¼º±â ¹× ¾Æ¹Ì³ë»ê ½Ã¾àÀÇ ºñ¿ëÀ» »ó½Â½ÃÅ´À¸·Î½á ¹Ì±¹ÀÇ ÀǾàǰ °³¹ßÀ» ¹æÇØÇϰí, ÆéƼµå ±â¹Ý Ä¡·á¹ýÀÇ ¿¬±¸¸¦ Áö¿¬½Ã۰í, »ý¸í°øÇÐ ¿¬±¸°³¹ßºñ¸¦ »ó½Â½Ãų °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ »óÈ£°ü¼¼¿Í ¹«¿ªÀÇ ±äÀå°ú ÇѰè Áõ°¡·Î ÀÎÇÑ ¼¼°è °æÁ¦¿Í ¹«¿ª¿¡ ´ëÇÑ ¾Ç¿µÇâÀ¸·Î ÀÎÇØ ±× ¿µÇâÀÌ ´õ¿í ±¤¹üÀ§ÇØÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡´Â ÆéƼµå ÇÕ¼º ½ÃÀåÀÇ ÇâÈÄ ¼ºÀåÀ» À̲ø °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¸¸¼ºÁúȯÀº Àå±â°£ÀÇ °Ç°­ »óÅÂ¿Í ºñ°¨¿°¼º Áúȯ(NCD)À̸ç, Á¾Á¾ Á¡Â÷ÀûÀ¸·Î ¹ßº´ÇÕ´Ï´Ù. ÆéƼµå ÇÕ¼ºÀº ƯÁ¤ ÆéƼµå°¡ Ç׿°Áõ ÀÛ¿ë°ú Ç×»êÈ­ ÀÛ¿ëÀ» °®°í ½ÉÇ÷°ü°è Áúȯ µîÀÇ ¿¹¹æ¿¡ µµ¿òÀÌ µÉ ¼ö Àֱ⠶§¹®¿¡ ¸¸¼ºÁúȯ¿¡ ´ëÇÑ ´ëÀÀ¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ƯÁ¤ ¼¼Æ÷ °úÁ¤ ¹× ½ÅÈ£ Àü´Þ °æ·Î¸¦ Ç¥ÀûÀ¸·Î ÇÔÀ¸·Î½á, ÆéƼµå´Â ¸¸¼ºÁúȯÀÇ »õ·Î¿î Ä¡·á¹ý ¹× °ü¸®¹ýÀ» Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 6¿ù È£ÁÖ Á¤ºÎ±â°üÀΠȣÁÖ º¸°Çº¹Áö¿¬±¸¼Ò(Australian Institute of Health and Welfare)´Â 2022³â ¸¸¼ºÁúȯÀ¸·Î ÀÎÇÑ ¿¬·ÉÇ¥ÁØÈ­ »ç¸Á·üÀº 10¸¸¸í´ç 490¸íÀ¸·Î 2021³â 10¸¸¸í´ç 459¸íÀ̾ú´Ù°í ¹àÇû½À´Ï´Ù. µû¶ó¼­ ¸¸¼ºÁúȯÀÇ ÀÌȯÀ² Áõ°¡°¡ ÆéƼµå ÇÕ¼º ½ÃÀåÀÇ È®´ë¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

CSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Peptide synthesis is the laboratory process of producing peptides, which are short chains of amino acids linked together by chemical bonds. These synthesized peptides find various applications in research, drug development, and medical diagnostics, particularly for generating precise sequences that mimic epitopes within specific protein domains.

The primary types of products and services involved in peptide synthesis include reagents, equipment, and services. Reagents in peptide synthesis are chemical compounds or substances used in the creation of peptides. Various technologies are employed in this process, including solid-phase peptide synthesis, solution-phase peptide synthesis, and hybrid and recombinant technology. These products and services are utilized by several end-users, including pharmaceutical and biotechnology companies, contract manufacturing and development organizations (CDMOs) and contract research organizations (CROs), as well as academic and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The peptide synthesis market research report is one of a series of new reports from The Business Research Company that provides peptide synthesis market statistics, including peptide synthesis industry global market size, regional shares, competitors with a peptide synthesis market share, detailed peptide synthesis market segments, market trends and opportunities, and any further data you may need to thrive in the peptide synthesis industry. This peptide synthesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peptide synthesis market size has grown strongly in recent years. It will grow from $5.69 billion in 2024 to $6.18 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rise in peptide-based vaccines, growth in biotechnology and biopharmaceuticals, demand for high-purity peptides, regulatory approvals and standardization.

The peptide synthesis market size is expected to see strong growth in the next few years. It will grow to $8.92 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to rapid growth in therapeutic peptides, increasing demand for customized peptides, growing role in drug discovery and development, focus on peptide libraries for screening. Major trends in the forecast period include development of peptide mimetics, adoption of novel amino acid derivatives, peptide cyclization techniques, innovations in solid-phase peptide synthesis (SPPs), utilization of click chemistry.

The forecast of 9.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. drug development by increasing the cost of automated peptide synthesizers and amino acid reagents sourced from Switzerland and China, thereby slowing research into peptide-based therapies and elevating biotech research and development expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic diseases is expected to drive the growth of the peptide synthesis market moving forward. Chronic diseases are long-term health conditions or non-communicable diseases (NCDs) that persist over extended periods and often develop gradually. Peptide synthesis plays a key role in addressing chronic diseases, as certain peptides possess anti-inflammatory and antioxidant properties that may help prevent conditions such as cardiovascular diseases. By targeting specific cellular processes and signaling pathways, peptides offer new therapeutic and management options for chronic diseases. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that in 2022, the age-standardized death rate due to chronic conditions was 490 per 100,000 people, an increase from 459 per 100,000 in 2021. As a result, the growing incidence of chronic diseases is driving the expansion of the peptide synthesis market.

The growth in healthcare expenditure is anticipated to accelerate the development of the peptide synthesis market. Healthcare expenditure is a broad measure that encompasses the financial resources allocated to healthcare services, medical treatments, public health programs, and the overall healthcare system. The high costs associated with peptide molecules in the pharmaceutical and nutrition sectors are attributed to their therapeutic potential, specificity, and low toxicity. For instance, in December 2023, according to the Centers for Medicare & Medicaid Services, a US-based federal agency, U.S. healthcare spending increased by 4.1% in 2022, totaling $4.5 trillion, surpassing the 3.2% increase seen in 2021. Therefore, the rise in healthcare expenditure is propelling the growth of the peptide synthesis market.

Major companies in the peptide synthesis market are strategically focusing on introducing advanced peptide synthesizers to gain a competitive edge. Notably, Gyros Protein Technologies launched the PurePep Sonata+ peptide synthesizer in March 2022, offering enhanced efficiency, speed, and accuracy compared to traditional synthesizers. This innovative technology incorporates real-time flow monitoring, ensuring precise and accurate fluid transfers across a diverse range of viscosities.

In May 2023, Biosynth International, Inc., a Swiss-based chemical manufacturing company, acquired Cambridge Research Biochemicals to strengthen its peptide division. This acquisition brings CRB's expertise in intricate peptide chemistry and fluorescent dye labeling, enhancing Biosynth's capabilities in the peptide synthesis market.

Major companies operating in the peptide synthesis market report are Thermo Fisher Scientific, Novo Nordisk A/S, Merck KGaA, Lonza Group, Kaneka Corporation, Uno Minda, Guizhou Xinbang Pharmaceutical Co. Ltd., Hybio Pharmaceutical Co. Ltd., GenScript Biotech, Bachem Holding AG, Syngene International, PolyPeptide Group AG, Mesa Labs Inc., CPC Scientific Inc., New England Peptide Inc., Biotage, ScinoPharm Taiwan Ltd., MP Biomedicals, USV Private Limited, CEM Corporation, Enamine Ltd., Creative Diagnostics, AnaSpec Inc., CSBio Company Inc., Alfa Chemistry, Advanced ChemTech, Gyros Protein Technologies AB, AAPPTec LLC, Biosynth International Inc., ProteoGenix

North America was the largest region in the peptide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the peptide synthesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The peptide synthesis market consists of revenues earned by entities by providing synthesis optimization, chemical ligation technology, and group strategy protection. The market value includes the value of related goods sold by the service provider or included within the service offering. The peptide synthesis market also includes sales of building blocks, chelators, coupling reagents, protecting reagents, amino acids, and resins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peptide Synthesis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peptide synthesis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for peptide synthesis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The peptide synthesis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Peptide Synthesis Market Characteristics

3. Peptide Synthesis Market Trends And Strategies

4. Peptide Synthesis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Peptide Synthesis Growth Analysis And Strategic Analysis Framework

6. Peptide Synthesis Market Segmentation

7. Peptide Synthesis Market Regional And Country Analysis

8. Asia-Pacific Peptide Synthesis Market

9. China Peptide Synthesis Market

10. India Peptide Synthesis Market

11. Japan Peptide Synthesis Market

12. Australia Peptide Synthesis Market

13. Indonesia Peptide Synthesis Market

14. South Korea Peptide Synthesis Market

15. Western Europe Peptide Synthesis Market

16. UK Peptide Synthesis Market

17. Germany Peptide Synthesis Market

18. France Peptide Synthesis Market

19. Italy Peptide Synthesis Market

20. Spain Peptide Synthesis Market

21. Eastern Europe Peptide Synthesis Market

22. Russia Peptide Synthesis Market

23. North America Peptide Synthesis Market

24. USA Peptide Synthesis Market

25. Canada Peptide Synthesis Market

26. South America Peptide Synthesis Market

27. Brazil Peptide Synthesis Market

28. Middle East Peptide Synthesis Market

29. Africa Peptide Synthesis Market

30. Peptide Synthesis Market Competitive Landscape And Company Profiles

31. Peptide Synthesis Market Other Major And Innovative Companies

32. Global Peptide Synthesis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Peptide Synthesis Market

34. Recent Developments In The Peptide Synthesis Market

35. Peptide Synthesis Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â